Jove
Visualize
Contact Us

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

496
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
496
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

440
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
440
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

405
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
405
Kidney Structure01:45

Kidney Structure

75.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.5K
Variability: Analysis01:11

Variability: Analysis

527
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
527
Random Variables01:09

Random Variables

17.9K
A random variable is a single numerical value that indicates the outcome of a procedure. The concept of random variables is fundamental to the probability theory and was introduced by a Russian mathematician, Pafnuty Chebyshev, in the mid-nineteenth century.
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haemodynamic effects of ketamine in the paediatric cardiac intensive care unit: insights from high-fidelity physiologic data.

Cardiology in the young·2026
Same author

ABO Incompatible Deceased Donor Liver Transplants in Infants (Age < 1 Year): A Single-Center Experience.

Pediatric transplantation·2026
Same author

Prelicensure Nursing Faculty's Motivations for Remaining in Academic Roles Following Student Incivility.

Nursing education perspectives·2026
Same author

Utilization and outcomes of COVID-19 positive donors in pediatric kidney transplantation-a population-based study.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Preemptive Pediatric Kidney Transplantation and Social Determinants of Health: Individual-Level Versus Area-Based Measures.

Pediatric transplantation·2026
Same author

Beyond biological risk: socioeconomic vulnerability and adverse pediatric kidney transplant outcomes.

Pediatric nephrology (Berlin, Germany)·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 11, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.4K

Medication Level Variability During First Year After Pediatric Kidney Transplantation.

Lidan Gu1, Finola Kane-Grade1, Michael Evans2

  • 1Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Pediatric Transplantation
|February 10, 2026
PubMed
Summary
This summary is machine-generated.

Tacrolimus level variability, measured by MLVI and IPV, is linked to graft failure risk in pediatric kidney transplants. Early and late variability, especially IPV in the first 3 months, predicts dnDSA development.

More Related Videos

Normothermic Machine Perfusion of Rat Kidneys for Transplantation
10:42

Normothermic Machine Perfusion of Rat Kidneys for Transplantation

Published on: January 27, 2026

139
A Modified Surgical Technique for Kidney Transplantation in Mice
10:38

A Modified Surgical Technique for Kidney Transplantation in Mice

Published on: July 22, 2022

7.2K

Related Experiment Videos

Last Updated: Feb 11, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.4K
Normothermic Machine Perfusion of Rat Kidneys for Transplantation
10:42

Normothermic Machine Perfusion of Rat Kidneys for Transplantation

Published on: January 27, 2026

139
A Modified Surgical Technique for Kidney Transplantation in Mice
10:38

A Modified Surgical Technique for Kidney Transplantation in Mice

Published on: July 22, 2022

7.2K

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Tacrolimus (TAC) level variability, assessed by Medication Level Variability Index (MLVI) and intrapatient variability (IPV), may impact graft outcomes in solid organ transplant recipients.
  • Optimal methods, timing, and thresholds for measuring TAC variability in pediatric kidney transplant recipients (peds KTRs) are not well-defined.

Purpose of the Study:

  • To evaluate the association between TAC variability (MLVI and IPV) and graft outcomes in peds KTRs.
  • To identify optimal time intervals for assessing TAC variability and its predictive value for graft failure and de novo donor-specific antibody (dnDSA) development.

Main Methods:

  • Retrospective analysis of 149 peds KTRs on maintenance TAC immunosuppression.
  • MLVI and IPV calculated across three intervals: 2-week to 3-month, 3- to 6-month, and 6- to 12-month post-transplant.
  • Landmark survival analysis and survival trees used to assess associations and identify thresholds, adjusting for covariates.

Main Results:

  • Both MLVI and IPV during the 2-week to 3-month and 6- to 12-month intervals were significantly associated with increased risk of graft failure.
  • IPV during the 2-week to 3-month interval was significantly associated with de novo donor-specific antibody (dnDSA) development.
  • Neither MLVI nor IPV predicted acute rejection; no significant associations were found for the 3- to 6-month interval.

Conclusions:

  • Tacrolimus variability, both MLVI and IPV, during early (0-3 months) and later (6-12 months) post-transplant periods is linked to graft failure risk in pediatric kidney transplant recipients.
  • Intrapatient variability (IPV) in the first 3 months is specifically associated with de novo donor-specific antibody development.